230 related articles for article (PubMed ID: 32315715)
1. An altered heparan sulfate structure in the articular cartilage protects against osteoarthritis.
Severmann AC; Jochmann K; Feller K; Bachvarova V; Piombo V; Stange R; Holzer T; Brachvogel B; Esko J; Pap T; Hoffmann D; Vortkamp A
Osteoarthritis Cartilage; 2020 Jul; 28(7):977-987. PubMed ID: 32315715
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate deficiency leads to hypertrophic chondrocytes by increasing bone morphogenetic protein signaling.
Kawashima K; Ogawa H; Komura S; Ishihara T; Yamaguchi Y; Akiyama H; Matsumoto K
Osteoarthritis Cartilage; 2020 Nov; 28(11):1459-1470. PubMed ID: 32818603
[TBL] [Abstract][Full Text] [Related]
3. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
[TBL] [Abstract][Full Text] [Related]
4. Chondrocytes respond to an altered heparan sulfate composition with distinct changes of heparan sulfate structure and increased levels of chondroitin sulfate.
Bachvarova V; Dierker T; Esko J; Hoffmann D; Kjellen L; Vortkamp A
Matrix Biol; 2020 Nov; 93():43-59. PubMed ID: 32201365
[TBL] [Abstract][Full Text] [Related]
5. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate functions are altered in the osteoarthritic cartilage.
Shamdani S; Chantepie S; Flageollet C; Henni-Chebra N; Jouan Y; Eymard F; Hay E; Cohen-Solal M; Papy-Garcia D; Chevalier X; Albanese P
Arthritis Res Ther; 2020 Dec; 22(1):283. PubMed ID: 33287871
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation.
Presto J; Thuveson M; Carlsson P; Busse M; Wilén M; Eriksson I; Kusche-Gullberg M; Kjellén L
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4751-6. PubMed ID: 18337501
[TBL] [Abstract][Full Text] [Related]
8. Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading.
Lorenz H; Wenz W; Ivancic M; Steck E; Richter W
Arthritis Res Ther; 2005; 7(1):R156-65. PubMed ID: 15642136
[TBL] [Abstract][Full Text] [Related]
9. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
10. Epiphyseal abnormalities, trabecular bone loss and articular chondrocyte hypertrophy develop in the long bones of postnatal Ext1-deficient mice.
Sgariglia F; Candela ME; Huegel J; Jacenko O; Koyama E; Yamaguchi Y; Pacifici M; Enomoto-Iwamoto M
Bone; 2013 Nov; 57(1):220-31. PubMed ID: 23958822
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of lentivirus-mediated siRNA targeting ADAMTS-5 on cartilage degradation in a rat model of osteoarthritis.
Chu X; You H; Yuan X; Zhao W; Li W; Guo X
Int J Mol Med; 2013 May; 31(5):1222-8. PubMed ID: 23546441
[TBL] [Abstract][Full Text] [Related]
12. Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes.
Dodge GR; Jimenez SA
Osteoarthritis Cartilage; 2003 Jun; 11(6):424-32. PubMed ID: 12801482
[TBL] [Abstract][Full Text] [Related]
13. Lithium protects against cartilage degradation in osteoarthritis.
Minashima T; Zhang Y; Lee Y; Kirsch T
Arthritis Rheumatol; 2014 May; 66(5):1228-36. PubMed ID: 24470226
[TBL] [Abstract][Full Text] [Related]
14. Deletion of Runx2 in Articular Chondrocytes Decelerates the Progression of DMM-Induced Osteoarthritis in Adult Mice.
Liao L; Zhang S; Gu J; Takarada T; Yoneda Y; Huang J; Zhao L; Oh CD; Li J; Wang B; Wang M; Chen D
Sci Rep; 2017 May; 7(1):2371. PubMed ID: 28539595
[TBL] [Abstract][Full Text] [Related]
15. Chondroprotective Effects of Ginsenoside Rg1 in Human Osteoarthritis Chondrocytes and a Rat Model of Anterior Cruciate Ligament Transection.
Cheng W; Jing J; Wang Z; Wu D; Huang Y
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28287423
[TBL] [Abstract][Full Text] [Related]
16. Chondrocyte-intrinsic Smad3 represses Runx2-inducible matrix metalloproteinase 13 expression to maintain articular cartilage and prevent osteoarthritis.
Chen CG; Thuillier D; Chin EN; Alliston T
Arthritis Rheum; 2012 Oct; 64(10):3278-89. PubMed ID: 22674505
[TBL] [Abstract][Full Text] [Related]
17. Activating enhancer binding protein 2 epsilon (AP-2ε)-deficient mice exhibit increased matrix metalloproteinase 13 expression and progressive osteoarthritis development.
Niebler S; Schubert T; Hunziker EB; Bosserhoff AK
Arthritis Res Ther; 2015 May; 17(1):119. PubMed ID: 25964075
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated transduction with Histone Deacetylase 4 ameliorates disease progression in an osteoarthritis rat model.
Gu XD; Wei L; Li PC; Che XD; Zhao RP; Han PF; Lu JG; Wei XC
Int Immunopharmacol; 2019 Oct; 75():105752. PubMed ID: 31310910
[TBL] [Abstract][Full Text] [Related]
19. WISP1/CCN4 aggravates cartilage degeneration in experimental osteoarthritis.
van den Bosch MH; Blom AB; Kram V; Maeda A; Sikka S; Gabet Y; Kilts TM; van den Berg WB; van Lent PL; van der Kraan PM; Young MF
Osteoarthritis Cartilage; 2017 Nov; 25(11):1900-1911. PubMed ID: 28735021
[TBL] [Abstract][Full Text] [Related]
20. Identification of soluble 14-3-3∊ as a novel subchondral bone mediator involved in cartilage degradation in osteoarthritis.
Priam S; Bougault C; Houard X; Gosset M; Salvat C; Berenbaum F; Jacques C
Arthritis Rheum; 2013 Jul; 65(7):1831-42. PubMed ID: 23552998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
